Read August's eNews here
An independent study on European/UK growth stage Biotech remuneration
PIR International’s 2022 EU/UK Biotech Board & Executive Remuneration Study is a data-driven resource that empowers executives, investors and the boardroom with the insights they need to improve board governance, top-level business decisions and truly excel. This strictly independent, anonymised and confidential remuneration study is designed to leverage participation from the entire European and UK biotech ecosystem that will give the very latest data to drive important insights for all decision-makers in the sector.…
BioIVT, LLC (“BioIVT”), a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug development purposes, today announced the promotion of Richard Haigh, PhD, to Chief Executive Officer (CEO) effective August 1. Dr. Haigh joined BioIVT in May 2022 as Chief Operating Officer and brings over 27 years’ experience in the life science research and diagnostics space covering products, consumables, and services, including over 15 years with Thermo Fisher Scientific/Life Technologies.
“I am delighted and honored to be taking on the…
Cambridge UK: 27 July 2022
RSM UK has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs of the One Nucleus Members, the Partner and One Nucleus in delivering on its core remit of supporting innovation.
Laragh Jeanroy, Managing Partner RSM East Anglia and Co-Head of Life Sciences at RSM commented
‘As a respected industry body for the life sciences industry and a key driver of business in the Cambridge and wider region, we are really pleased to become a partner of One Nucleus and excited to explore opportunities for…
Author: Helen Baxter, Vice President, North Highland
I joined fellow Life Science enthusiasts at the OnHelix conference in Cambridge at the beginning of the month to listen and learn to some of the latest thinking in Innovation in the industry. A range of experts talked about BioInnovation in the pharma and biotech industry at the latest OnHelix conference in Cambridge July 2022. Here are some of the key themes that emerged from the conference.
1. The convergence of technology into Life Sciences companies has critical and long reaching symptoms which are creating new opportunities for…
Sian Steele appointed Chair of the Boards of Howard Investments and Howard Ventures
Andrew Hynard appointed Non-Executive Director
Cambridge, 28th July 2022: Cambridge-based property developer and investor Howard Group is pleased to announce Sian Steele as its new Board Chair.
Sian will take up the position from 1st August after serving for the past two years as a Non-Executive Director of the Group.
Sian is well known in the Cambridge business community having previously worked as a Senior Partner in the Cambridge office for PwC, and has more than 30…
Cpl Life Sciences UK is proud to have been part of the trailblazer groups for the first clinical research apprenticeships in industry – Clinical Trial Specialist degree apprenticeship (Level 6), and the Regulatory Affairs Specialist (Level 7) both launched in 2019. It is part of our ongoing work and commitment to ensure the worsening skills shortages in the UK life sciences sectors are addressed, through proactive initiatives and programmes to bring in new talent and upskill/reskill current workforces. We have always been passionate about ‘giving back’ and have dedicated a…
One Nucleus Summer Life Sciences Dinner, Wednesday 6 July 2022
On the eve of our annual ON Helix Conference, we were pleased to welcome over 100 guests to attend the inaugural One Nucleus Summer Life Sciences Dinner on the stunning grounds of Babraham Research Campus.
The evening began with a networking drinks reception and once seated, Tony Jones, CEO, One Nucleus thanked the sponsors and guests for attending and supporting the evening.
In between courses, names were pulled out of a hat and six lucky winners received a copy of the book, ‘Cambridge per diem’ by Rosie Zanders. In this book,…
Link below to EY blog by Pamela Spence (EY PArtner)
https://www.linkedin.com/pulse/how-you-prioritize-your-supply-chain-inv…
Invited guests enjoyed a look around Nottingham CRO Cellomatics Biosciences’ new lab facilities at Colwick Quays Business Park last week, at a special launch event hosted by the company’s CEO and founder, Dr Shailendra Singh.
Cellomatics moved into the purpose-built premises last month in the wake of rising demand for its bespoke preclinical and early drug discovery phase laboratory services. Representing a three-fold increase in the company’s footprint, the facility covers approximately 5,500 sq ft of space across two levels and allows rooms for further expansion.
Members of the drug…